Immuno Mycologies Revenue, Growth & Competitor Profile

DBA IMMUNO-MYCOLOGICS, INC.

Company Profile & Annual Report for Immuno Mycologies

Access the complete profile.

Immuno Mycologies Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 325413 In-Vitro Diagnostic Substance Manufacturing 525 Pension Funds, Trusts & Other Financial Vehicles
Address	2701 Corporate Centre Dr. Norman, OK 73069

Note: Revenues for privately held companies are statistical evaluations.


Immuno Mycologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Immuno Mycologies's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Immuno Mycologies is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Immuno Mycologies Annual Revenue and Growth Rate

Immuno Mycologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Immuno Mycologies's revenues are gauged from an analysis of company filings.

Immuno Mycologies's Income Statement (based on Industry Averages)

Immuno Mycologies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Immuno Mycologies is developing and marketing. Immuno Mycologies doesn't have any recent trademark applications, indicating Immuno Mycologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MYCODDR Reagents for medical use	09/01/2023
S?NA Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, fungal infections	09/01/2023
CLARUS Diagnostic reagents for clinical or medical laboratory use	09/01/2023

See all trademarks and details in the Full Report.

Market Share of Immuno Mycologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Immuno Mycologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Immuno Mycologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
IMMUNO MYCOLOGIES	Norman, OK	100
ADVANCED PROCESSING TECHNOLOGY	Norman, OK	10
NEXT FRONTIER	Norman, OK	3
COOK ASHTON ROBINSON	Norman, OK	1

Future Competition: Immuno Mycologies's Fastest Growing Competitors

These companies are in the same general field as Immuno Mycologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)